Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly
T Wasil, SM Lichtman - The Oncologist, 2005 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Describe pharmacokinetic changes associated with aging. Describe concepts of geriatric …
Describe pharmacokinetic changes associated with aging. Describe concepts of geriatric …
Cancer, clinical pharmacology, and aging
LF Hutchins, DA Lipschitz - Clinics in Geriatric Medicine, 1987 - Elsevier
Cancer, Clinical Pharmacology, and Aging - ScienceDirect Skip to main contentSkip to article
Elsevier logo Journals & Books Search RegisterSign in View PDF Download full issue Search …
Elsevier logo Journals & Books Search RegisterSign in View PDF Download full issue Search …
Pharmacology of antineoplastic agents in older cancer patients
SM Lichtman, JA Skirvin, S Vemulapalli - Critical reviews in oncology …, 2003 - Elsevier
Persons over the age of 65 years are the fastest growing segment of the United States
population. In the next 30 years it will comprise over 20% of the population. Fifty percent of …
population. In the next 30 years it will comprise over 20% of the population. Fifty percent of …
Problems in the use of anticancer drugs in the elderly
JE Phister, SG Jue, BJ Cusack - Drugs, 1989 - Springer
The elderly represent a special challenge to the physician in providing effective cancer
chemotherapy. Though they represent the majority of the patients who eventually will need …
chemotherapy. Though they represent the majority of the patients who eventually will need …
Chemotherapy in the elderly
SM Lichtman - Seminars in oncology, 2004 - Elsevier
Persons over the age of 65 years are the fastest growing segment of the US population. In
the next 30 years it will comprise over 20% of the population. More than 50% of all cancers …
the next 30 years it will comprise over 20% of the population. More than 50% of all cancers …
Pharmacology of cancer chemotherapy in the older person
SD Baker, LB Grochow - Clinics in geriatric medicine, 1997 - Elsevier
With more widespread use of effective chemotherapy, more elderly patients are candidates
for treatment with cytotoxic drugs. This article reviews and discusses the relevant age …
for treatment with cytotoxic drugs. This article reviews and discusses the relevant age …
Pharmacology of antineoplastic agents in older cancer patients.
SM Lichtman, JA Skirvin - Oncology (Williston Park, NY), 2000 - europepmc.org
The fastest growing segment of the US population is the group over the age of 65 years. In
the next 30 years, this group will comprise over 20% of the population. Because 60% of all …
the next 30 years, this group will comprise over 20% of the population. Because 60% of all …
Cancer chemotherapy in the older patient
D Cova, L Balducci - Comprehensive geriatric oncology, 2004 - taylorfrancis.com
This chapter explores the effects of aging on the pharmacology of antineoplastic agents.
Aging involves progressive changes in organ and cellular function and in tumor growth (see …
Aging involves progressive changes in organ and cellular function and in tumor growth (see …
General guidelines for the management of older patients with cancer.
L Balducci, J Yates - Oncology (Williston Park, NY), 2000 - europepmc.org
Because aging is highly individualized, the best guide to treatment of the older patient with
cancer may be provided by a comprehensive assessment that evaluates such diverse areas …
cancer may be provided by a comprehensive assessment that evaluates such diverse areas …
Aging and pharmacology
RE Vestal - Cancer: Interdisciplinary International Journal of the …, 1997 - Wiley Online Library
Research on aging and pharmacology in humans has been termed geriatric clinical
pharmacology, which is an established subdiscipline within the broad field of clinical …
pharmacology, which is an established subdiscipline within the broad field of clinical …